Company Suven Pharmaceuticals Limited

Equities

SUVENPHAR

INE03QK01018

Pharmaceuticals

End-of-day quote NSE India S.E. 06:00:00 2024-07-11 pm EDT 5-day change 1st Jan Change
848.1 INR -0.70% Intraday chart for Suven Pharmaceuticals Limited +4.24% +17.34%

Business Summary

Suven Pharmaceuticals Limited is an India-based company. The Company is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology, and chemical companies. The Company operates through Pharmaceuticals Manufacturing and Services segment. Its geographical segments include India, the United States, Europe, and others. In India, the Company sells bulk drugs and intermediates, chemicals, and services. In the United States, the Company sells intermediates and services. In Europe, the Company sells bulk drugs and intermediates. In other countries, the Company sells bulk drugs, intermediates, and services. The Company’s wholly owned subsidiary is Suven Pharma Inc.

Number of employees: 1,193

Sales per Business

INR in Million2022Weight2023Weight Delta
Manufacturing (CRAMS)
100.0 %
13,202 100.0 % 13,403 100.0 % +1.52%

Sales per region

INR in Million2022Weight2023Weight Delta
Europe
86.7 %
11,048 83.7 % 11,618 86.7 % +5.16%
United States
6.2 %
585 4.4 % 834 6.2 % +42.47%
Rest of the World
4.5 %
1,126 8.5 % 600 4.5 % -46.70%
India
2.6 %
443 3.4 % 352 2.6 % -20.64%

Managers

Managers TitleAgeSince
Chief Executive Officer - 23-09-28
Director of Finance/CFO 30 Dec. 31
Chief Tech/Sci/R&D Officer - -
Compliance Officer - -
Director/Board Member - 23-09-28
Corporate Officer/Principal - 23-09-30
Corporate Officer/Principal - 23-09-28
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Corporate Officer/Principal 63 -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 67 23-09-28
Director/Board Member 48 Nov. 08
Director/Board Member 62 Nov. 08
Director/Board Member 62 23-09-28
Chairman 64 23-09-28
Director/Board Member - 23-09-28
Director/Board Member 66 23-09-28
Director/Board Member - 23-09-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 254,564,956 229,023,361 ( 89.97 %) 0 89.97 %

Shareholders

NameEquities%Valuation
152,730,000 60.00 % 1 472 M ₹
DSP Asset Managers Pvt. Ltd.
4.927 %
12,543,323 4.927 % 121 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
3.741 %
9,522,793 3.741 % 92 M ₹
HSBC Asset Management (India) Pvt Ltd.
1.444 %
3,675,603 1.444 % 35 M ₹
Tata Asset Management Pvt Ltd.
0.9965 %
2,536,773 0.9965 % 24 M ₹
SBI Life Insurance Co. Ltd. (Investment Portfolio)
0.6718 %
1,710,156 0.6718 % 16 M ₹
Axis Asset Management Co. Ltd.
0.6672 %
1,698,583 0.6672 % 16 M ₹
Canara Robeco Asset Management Co. Ltd.
0.6589 %
1,677,284 0.6589 % 16 M ₹
Sundaram Asset Management Co. Ltd.
0.4548 %
1,157,867 0.4548 % 11 M ₹
360 ONE Asset Management Ltd.
0.2585 %
657,947 0.2585 % 6 M ₹

Company contact information

Suven Pharmaceuticals Ltd.

Door No. 8-2-334, 3rd Floor SDE Serene Chambers, Road No.5

500034, Hyderabad

+91 40 2354 9414

http://www.suvenpharm.com
address Suven Pharmaceuticals Limited(SUVENPHAR)

Group companies

NameCategory and Sector
Pharmaceuticals: Major

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
D-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
848.1 INR
Average target price
670.5 INR
Spread / Average Target
-20.94%
Consensus
  1. Stock Market
  2. Equities
  3. SUVENPHAR Stock
  4. Company Suven Pharmaceuticals Limited